NEW YORK (360Dx) – MBio Diagnostics today announced it has been awarded a Phase II contract from the US Defense Advanced Research Projects Agency for the further development of a portable multiplexed immunoassay system.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.